Previous Close | 86.54 |
Open | 86.41 |
Bid | 85.97 x 100 |
Ask | 86.38 x 100 |
Day's Range | 86.02 - 87.31 |
52 Week Range | 52.88 - 88.00 |
Volume | |
Avg. Volume | 558,982 |
Market Cap | 9.135B |
Beta (5Y Monthly) | 1.00 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.87 |
Earnings Date | Oct 30, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 99.79 |
It's been a pretty great week for Intra-Cellular Therapies, Inc. ( NASDAQ:ITCI ) shareholders, with its shares surging...
Intra-Cellular Therapies ( NASDAQ:ITCI ) Third Quarter 2024 Results Key Financial Results Revenue: US$175.4m (up 39...